Market Cap 45.72M
Revenue (ttm) 0.00
Net Income (ttm) -15.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 63,300
Avg Vol 105,274
Day's Range N/A - N/A
Shares Out 21.67M
Stochastic %K 38%
Beta 2.24
Analysts Strong Sell
Price Target $13.00
Joby099
Joby099 Dec. 1 at 5:12 PM
0 · Reply
Joby099
Joby099 Dec. 1 at 10:07 AM
0 · Reply
Joby099
Joby099 Nov. 30 at 12:53 AM
0 · Reply
Joby099
Joby099 Nov. 29 at 6:53 PM
$UVXY $ALRN $AIRE $BDRX $TMC If you want to stay ahead heading into 2026, watch this! https://www.youtube.com/watch?v=abf51b0Hm24
0 · Reply
ProfitGainer
ProfitGainer Oct. 29 at 6:17 PM
$RNTX $ALRN This could run to $3+ on high volume.
0 · Reply
Dollar_1
Dollar_1 Oct. 29 at 12:04 AM
$ALRN https://ir.reintx.com/node/10426/html
0 · Reply
ProfitGainer
ProfitGainer Oct. 7 at 7:05 PM
$ALRN This could rocket to $3+ any day. $DVLT $PSTV
0 · Reply
Dollar_1
Dollar_1 Jun. 26 at 8:52 PM
0 · Reply
Dollar_1
Dollar_1 May. 15 at 12:46 AM
$ALRN https://ir.reintx.com/node/10191/html
0 · Reply
Dollar_1
Dollar_1 Apr. 28 at 12:59 PM
$ALRN https://www.prnewswire.com/news-releases/rein-therapeutics-announces-abstract-accepted-for-presentation-at-the-american-thoracic-society-2025-international-conference-302439327.html
0 · Reply
Latest News on ALRN
No data available.
Joby099
Joby099 Dec. 1 at 5:12 PM
0 · Reply
Joby099
Joby099 Dec. 1 at 10:07 AM
0 · Reply
Joby099
Joby099 Nov. 30 at 12:53 AM
0 · Reply
Joby099
Joby099 Nov. 29 at 6:53 PM
$UVXY $ALRN $AIRE $BDRX $TMC If you want to stay ahead heading into 2026, watch this! https://www.youtube.com/watch?v=abf51b0Hm24
0 · Reply
ProfitGainer
ProfitGainer Oct. 29 at 6:17 PM
$RNTX $ALRN This could run to $3+ on high volume.
0 · Reply
Dollar_1
Dollar_1 Oct. 29 at 12:04 AM
$ALRN https://ir.reintx.com/node/10426/html
0 · Reply
ProfitGainer
ProfitGainer Oct. 7 at 7:05 PM
$ALRN This could rocket to $3+ any day. $DVLT $PSTV
0 · Reply
Dollar_1
Dollar_1 Jun. 26 at 8:52 PM
0 · Reply
Dollar_1
Dollar_1 May. 15 at 12:46 AM
$ALRN https://ir.reintx.com/node/10191/html
0 · Reply
Dollar_1
Dollar_1 Apr. 28 at 12:59 PM
$ALRN https://www.prnewswire.com/news-releases/rein-therapeutics-announces-abstract-accepted-for-presentation-at-the-american-thoracic-society-2025-international-conference-302439327.html
0 · Reply
ZenRevolution
ZenRevolution Mar. 22 at 6:26 AM
$ALUR was the best premarket trade of the day, jumping from $3.00 to $4.18 after that after-hours PR! 💯💰 ✅ $HOLO running strong on 2024 revenue release news! ✅ $SGLY another 🇨🇳 mover with momentum! ✅ $IBO – a wild 300% runner on NO news! 📈👀 📊 Taking this a step further... The U.S. intragastric balloon market is set to triple in the next 7 years, reaching $144M US & $1.1B globally. ALRN’s share? 30% of that market = serious buyout potential. 💎🔥 💰 Valuation math doesn't lie: $ALRN at $3.58? Market cap = $21.3M Potential buyout? $39.33/share! 🚀📈 💭 "When you have the best product, you sell to the highest bidder." – Remember that. 📌 Don't miss the next big move! Tap in now 👉🔗
1 · Reply
krakensos
krakensos Feb. 28 at 3:53 PM
$ALRN what happen no news in alrn or rntx (new name)
0 · Reply
Sthenniabal
Sthenniabal Feb. 4 at 4:55 PM
$ALRN $BYSI $OVID 🤫 Shhh… bears trap in action... SQUEEZE -->> CNSP showing signs of life! 🍋 🚀 Rumors flying… PR drop incoming on some BIG moves?! 😏 You know how these moves go - quiet before the storm. Don’t say I didn’t warn ya…🔥 LFG! 🚀🫡
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 25 at 4:39 PM
$ALRN Aileron Therapeutics, Inc. (NASDAQ:ALRN): Shifting Focus to Orphan Pulmonary and Fibrosis Indications https://beyondspx.com/article/aileron-therapeutics-alrn-navigating-the-frontiers-of-orphan-pulmonary-and-fibrosis-treatments
0 · Reply
MysticWolfram78
MysticWolfram78 Jan. 17 at 4:14 PM
$ALRN $BYSI $OVID 🚀 MYNZ 🚀 PRs incoming! Spreading the message suggest big news. My bet: FDA re-submission (as hinted by Petra), but any update could be huge. IR presentation points to clinical studies next. MoonDay!
0 · Reply
lecorb
lecorb Jan. 13 at 5:00 PM
$ALRN to $RNTX 12:30 PM EST, 01/10/2025 (MT Newswires) -- Rein Therapeutics (ALRN), formerly Aileron Therapeutics, said Friday that it changed names to reflect its focus on developing first-in-class treatments for rare pulmonary and fibrosis diseases. The company's stock will begin trading under the new Nasdaq ticker "RNTX" on Monday, it added. The company also said its key goals for 2025 include initiating a phase 2 trial of LTI-03 for the treatment of idiopathic pulmonary fibrosis in H1.
0 · Reply
Dollar_1
Dollar_1 Jan. 10 at 4:38 PM
$ALRN alrn will be RNTX starting Monday Jan 13th
0 · Reply
Husse47Jc
Husse47Jc Jan. 9 at 6:14 PM
$ALRN be ready for $ALXO
0 · Reply
Husse47Jc
Husse47Jc Jan. 7 at 5:08 PM
$ALRN watch $ALXO partners with eli lilly since 2021 what can go wrong? Nothingggg found bottom now up from here
0 · Reply
Ali22722
Ali22722 Dec. 30 at 10:34 AM
$ALRN keeeeeeeep an eye on this one 🔥🔥🔥🔥 Many will regret not having it 😉
1 · Reply
CursedTrader
CursedTrader Dec. 26 at 10:03 PM
$ALRN Huge inflow 🚀
0 · Reply
frchmn
frchmn Dec. 26 at 10:50 AM
$ALRN watching 👀
0 · Reply